Myriad Genetics
(NASDAQ) MYGN
Myriad Genetics Financials at a Glance
Market Cap
$512.85M
Revenue (TTM)
$829.00M
Net Income (TTM)
-$399.90M
EPS (TTM)
-$4.32
P/E Ratio
-1.26
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Price
$5.83
Volume
137,340
Open
$5.45
Price
$5.83
Volume
137,340
Open
$5.45
Previous Close
$5.83
Daily Range
$5.35 - $5.86
52-Week Range
$3.53 - $8.59
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
1.30 (Average)
Price
$5.83
Volume
137,340
Open
$5.45
Previous Close
$5.83
Daily Range
$5.35 - $5.86
52-Week Range
$3.53 - $8.59
Estimated Earnings Date
Aug 4, 2026
MYGN News
MYGN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Myriad Genetics
Industry
Biotechnology
Sector
Health CareEmployees
2,700
CEO
Samraat S Raha, MBA
Website
www.myriad.comHeadquarters
Salt Lake City, UT 84116, US
MYGN Financials
Key Financial Metrics (TTM)
Gross Margin
69.96%
Operating Margin
-46.26%
Net Income Margin
-48.24%
Return on Equity
-109.09%
Return on Capital
-11.73%
Return on Assets
-59.36%
Earnings Yield
-79.37%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$512.85M
Shares Outstanding
94.45M
Volume
137.34K
Avg. Volume
1.54M
Financials (TTM)
Gross Profit
$580.00M
Operating Income
-$383.50M
EBITDA
-$334.20M
Operating Cash Flow
$2.40M
Capital Expenditure
-$25.60M
Free Cash Flow
-$23.20M
Cash & ST Invst.
$124.40M
Total Debt
$211.50M
Myriad Genetics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$200.40M
+2.3%
Gross Profit
$137.60M
+2.5%
Gross Margin
68.66%
N/A
Market Cap
$512.85M
N/A
Market Cap/Employee
$188.20K
N/A
Employees
2,725
N/A
Net Income
-$34.10M
-34000.0%
EBITDA
-$17.50M
-23.2%
Quarterly Fundamentals
Total Cash
$124.40M
+35.5%
Total Debt
$211.50M
+34.2%
Accounts Receivable
$123.80M
+2.8%
Inventory
$27.90M
-1.4%
Long Term Debt
$204.40M
+39.3%
Short Term Debt
$7.10M
-34.9%
Return on Assets
-59.36%
N/A
Return on Invested Capital
-70.56%
N/A
Free Cash Flow
-$22.20M
+9.8%
Operating Cash Flow
-$15.70M
+3.7%